These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11828860)

  • 21. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.
    Hoffman RM; Angelidou KN; Brummel SS; Saidi F; Violari A; Dula D; Mave V; Fairlie L; Theron G; Kamateeka M; Chipato T; Chi BH; Stranix-Chibanda L; Nematadzira T; Moodley D; Bhattacharya D; Gupta A; Coletti A; McIntyre JA; Klingman KL; Chakhtoura N; Shapiro DE; Fowler MG; Currier JS;
    HIV Clin Trials; 2018 Dec; 19(6):209-224. PubMed ID: 30890061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children.
    Nicholson O; Mellins C; Dolezal C; Brackis-Cott E; Abrams EJ
    Patient Educ Couns; 2006 Jun; 61(3):405-10. PubMed ID: 16246515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings.
    Carter RJ; Dugan K; El-Sadr WM; Myer L; Otieno J; Pungpapong N; Toro PL; Abrams EJ;
    J Acquir Immune Defic Syndr; 2010 Nov; 55(3):404-10. PubMed ID: 20595905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
    Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
    AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.
    Diaz CM; Segura ER; Luz PM; Clark JL; Ribeiro SR; De Boni R; Eksterman L; Moreira R; Currier JS; Veloso VG; Grinsztejn B; Lake JE
    BMC Infect Dis; 2016 Aug; 16():376. PubMed ID: 27503230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
    Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.
    Gwadz M; Cleland CM; Applegate E; Belkin M; Gandhi M; Salomon N; Banfield A; Leonard N; Riedel M; Wolfe H; Pickens I; Bolger K; Bowens D; Perlman D; Mildvan D;
    AIDS Behav; 2015 Oct; 19(10):1801-17. PubMed ID: 25835462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316.
    Cunningham CK; Balasubramanian R; Delke I; Maupin R; Mofenson L; Dorenbaum A; Sullivan JL; Gonzalez-Garcia A; Thorpe E; Rathore M; Gelber RD
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):800-7. PubMed ID: 15213563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy.
    Brittain K; Mellins CA; Remien RH; Phillips TK; Zerbe A; Abrams EJ; Myer L
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):379-386. PubMed ID: 30939530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study.
    Kleeberger CA; Phair JP; Strathdee SA; Detels R; Kingsley L; Jacobson LP
    J Acquir Immune Defic Syndr; 2001 Jan; 26(1):82-92. PubMed ID: 11176272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.
    Marazzi MC; Palombi L; Nielsen-Saines K; Haswell J; Zimba I; Magid NA; Buonomo E; Scarcella P; Ceffa S; Paturzo G; Narciso P; Liotta G
    AIDS; 2011 Aug; 25(13):1611-8. PubMed ID: 21673553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study.
    Moosa A; Gengiah TN; Lewis L; Naidoo K
    BMC Infect Dis; 2019 Sep; 19(1):775. PubMed ID: 31488063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
    Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
    BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L
    J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004-2009.
    Mayanja BN; Shafer LA; Van der Paal L; Kyakuwa N; Ndembi N; Hughes P; Maher D; Grosskurth H
    Trop Med Int Health; 2012 Mar; 17(3):343-52. PubMed ID: 22212561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility.
    Mostashari F; Riley E; Selwyn PA; Altice FL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):341-8. PubMed ID: 9704939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.
    Turner BJ; Newschaffer CJ; Zhang D; Cosler L; Hauck WW
    Med Care; 2000 Sep; 38(9):911-25. PubMed ID: 10982113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.